Among competitors one swimmer had vast experience, Thomas Heilman, 17, swam in the Olympics last summer and broke Michael ...
The new mens range debuted at a VIP fashion show in Palm Beach last week, and will arrive in stores in February for the ...
Lilly Pulitzer is dipping a pastel-painted toe into the world of menswear. After more than six decades of treating its ...
Please go ahead. Thank you, Paul, and good morning, everybody. Thanks for joining us for Eli Lilly and Company's Q3 2024 earnings call. I'm Joe Fletcher, Senior Vice President of Investor Relations.
Eli Lilly and Company reported third quarter results and missed expectations and had to lower its guidance, which was a huge disappointment for investors. But in the last few years, Eli Lilly was ...
Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...
Eli Lilly has dropped (PDF) the lead candidate from its $2.4 billion takeover of Dice Therapeutics, shifting the focus of its oral IL-17 psoriasis program to a follow-up molecule. Lilly kicked DC ...
Of Lilly’s $3.11 billion in quarterly sales from Mounjaro, $2.4 billion came from the U.S. Related Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Weight-loss drugmaker Eli Lilly delivered lower sales and earnings per share than expected in the third ...
A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in a trial, the company said Tuesday. In the phase 3 study ...
Both Lilly and J&J are seeking to expand their respective treatments into Crohn’s disease, following approvals for ulcerative colitis. J&J submitted its supplemental Biologics License Application for ...
Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...